Search

Search Constraints

You searched for: Author/Creator Ascierto, Maria Libera

Search Results

1. 518 Phase 1B trial of monalizumab (NKG2A inhibitor) plus durvalumab: safety and efficacy in patients with metastatic ovarian, cervical, and microsatellite-stable endometrial cancers. (4th December 2020)

2. Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. Issue 1 (4th July 2019)

3. Intradermal influenza vaccination in complete remission cancer patients: molecular insights. (7th November 2013)

4. IRF-1 responsiveness to immune cytokines predicts different cancer phenotypes. (7th November 2013)

6. Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, December 5th 2015. Issue 1 (18th October 2016)

7. The immune‐related role of BRAF in melanoma. Issue 1 (6th August 2014)

8. Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. Issue 1 (22nd May 2019)